The 2 most recent market catalysts affecting $AIFF, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 25, 2026
Corporate Catalyst
Bullish
Impact 75
Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care
Firefly Neuroscience (AIFF) has announced a strategic partnership with NeuroSigma to broaden the availability of the Monarch eTNS System, an FDA-cleared non-drug treatment for pedi…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 65
Firefly Neuroscience And Next Health Partner To Launch Precision Cognitive Health Platform Integrating Firefly’s AI-Powered, FDA-Cleared EEG/ERP Brain Biomarker Technology With Personalized Cognitive Peptide Protocols
Firefly Neuroscience (AIFF) and Next Health have formed a strategic partnership to develop a precision cognitive health platform. This initiative is significant because it combines…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.